biomedicina slovenica

"Glioblastom" : 38-137

  1. Car Milan; Šteblaj Simona; Mitrović Goran; Dolenc-Stražar Zvezdana; Popović Mara
    Corticosteroid-induced immunodeficiency in a patient with gliomatosis cerebri
    2019 ►
  2. Šamec Neja; Zottel Alja; Videtič Paska Alja; Jovchevska Ivana
    Nanomedicine and immunotherapy
    2020 ►
  3. Velnar Tomaž; Bošnjak Roman; Bunc Gorazd; Maver Uroš; Gradišnik Lidija
    The isolation of human glioblastoma cells
    2019 ►
  4. Novak Metka; Koprivnikar Krajnc Miha; Hrastar Barbara; Breznik Barbara; Majc Bernarda; Hira Vashendriya V. V.; Mlinar Mateja; Rotter Ana; Porčnik Andrej; Bošnjak Roman; Mlakar Jernej; Lah Turnšek Tamara
    CCL5/CCR5 signaling is important for invasion of glioblastoma in its microenvironment
    2019 ►
  5. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Šribar Jernej; Sorokin Maxim; Nikitin Daniil; Buzdin Anton A.; Komel Radovan
    High FREM2 gene and protein expression are associated with favorable prognosis of IDH-WT glioblastomas
    2019 ►
  6. Zottel Alja; Jovchevska Ivana; Šamec Neja; Mlakar Jernej; Šribar Jernej; Križaj Igor; Skoblar Vidmar Marija; Komel Radovan
    Nanobodies anti-TUFM (Nb225) and anti-vimentin (Nb79) show cytotoxic and anti-migratory effect in glioblastoma cells
    2019 ►
  7. Komel Radovan; Šamec Neja; Jovchevska Ivana; Zottel Alja; Vidak Marko; Mlakar Jernej; Skoblar Vidmar Marija
    Can an advanced search for cancer stem cell biomarkers lead to efficient glioblastoma gene/immuno-therapy?
    2019 ►
  8. Matos Boštjan; Boštjančič Emanuela; Matjašič Alenka; Popović Mara; Glavač Damjan
    Dynamic expression of 11 miRNAs in 83 consecutive primary and corresponding recurrent glioblastoma: correlation to treatment, time to recurrence, overall survival and MGMT methylation status
    2019 ►
  9. Zottel Alja; Jovchevska Ivana; Šamec Neja; Mlakar Jernej; Šribar Jernej; Križaj Igor; Skoblar Vidmar Marija; Komel Radovan
    Nanobodies anti-TufM (Nb225) and anti-vimentin (Nb79) are cytotoxic to glioblastoma (stem) cells and reduce cell migration
    2019 ►
  10. Koprivnikar Krajnc Miha; Novak Metka; Pestell Richard G.; Lah Turnšek Tamara
    Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme
    2019 ►
  11. Matjašič Alenka; Zupan Andrej; Boštjančič Emanuela; Pižem Jože; Popović Mara; Kolenc Danijela
    A novel PTPRZ1-ETV1 fusion in gliomas
    2019 ►
  12. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Sorokin Maxim; Nikitin Daniil; Buzdin Anton A.; Komel Radovan
    High FREM2 gene and protein expression are associated with favorable prognosis of IDH-WT glioblastomas
    2019 ►
  13. Zottel Alja; Jovchevska Ivana; Šamec Neja; Mlakar Jana; Križaj Igor; Skoblar Vidmar Marija; Komel Radovan
    Nanobodies NB79 (anti-vimentin), NB179 (anti- NAP1L1), NB225 (anti-TUFM) and NB314 (anti- DPYSL2) are cytotoxic and reduce migration of glioblastoma (stem) cells
    2019 ►
  14. Jovchevska Ivana; Šamec Neja; Zottel Alja; Mlakar Jana; Sorokin M; Buzdin Anton A.; Komel Radovan
    Increased FREM2 gene and protein expression is associated to glioblastoma malignant progression and recurrence
    2019 ►
  15. Zottel Alja; Videtič Paska Alja; Jovchevska Ivana
    Nanotechnology meets oncology
    2019 ►
  16. Kolenc Danijela; Jakovčević Antonia; Macan Marija; Žarković Kamelija
    The co-expression of 4-hydroxynonenal and prominin-1 in glioblastomas
    2011 ►
  17. Prunk Mateja; Perišić Milica; Sabotič Jerica; Švajger Urban; Kos Janko
    Increased cystatin F levels correlate with decreased cytotoxicity of cytotoxic T cells
    2019 ►
  18. Žarković Kamelija; Juric Gordana; Waeg Georg; Kolenc Danijela; Žarković Neven
    Immunohistochemical appearance of HNE-protein conjugates in human astrocytomas
    2005 ►
  19. Feigl Guenther C.; Heckl Stefan; Kullmann Marcel; Filip Zoltan; Decker Karlheinz; Klein Jan; Ernemann Ulrike; Tatagiba Marcos; Velnar Tomaž; Ritz Rainer
    Review of first clinical experiences with a 1.5 Tesla ceiling-mounted moveable intraoperative MRI system in Europe
    2019 ►
  20. Šimenc Janez; Jurič Damijana Mojca; Lipnik-Štangelj Metoda
    NADPH oxidase inhibitor VAS2870 prevents staurosporine-induced cell death in rat astrocytes
    2019 ►
  21. Matos Boštjan; Boštjančič Emanuela; Matjašič Alenka; Popović Mara; Glavač Damjan
    Dynamic expression of 11 miRNAs in 83 consecutive primary and corresponding recurrent glioblastoma
    2018 ►
  22. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Šribar Jernej; Križaj Igor; Muyldermans Serge; Buzdin Anton A.; Komel Radovan
    Nanobodies and OncoFinder
    2018 ►
  23. Vidak Marko; Komel Radovan; Debeljak Nataša; Serša Gregor; Lah Turnšek Tamara
    Analiza celičnih komunikacijskih omrežij potencialnih označevalcev matičnih celic multiformnega glioblastoma
    [Analysis of cell communication networks for potential markers of glioblastoma multiforme stem cells]
    2018 ►
  24. Jovchevska Ivana
    Genetic secrets of long-term glioblastoma survivors
    2018 ►
  25. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Muyldermans Serge; Buzdin Anton A.; Komel Radovan
    Combination of nanobody proteomics and OncoFinder bioinformatics in glioblastoma research and targeting
    2018 ►
  26. Zottel Alja; Šamec Neja; Vidak Marko; Jovchevska Ivana
    From basic glioblastoma proteomics to promising diagnostic and therapeutic tools
    2018 ►
  27. Šamec Neja; Komel Radovan; Čurin-Šerbec Vladka; Veranič Peter; Kos Janko
    Uporabnost nano-protiteles pri razvoju ciljanega zdravljenja glioblastoma
    [Implementation of nanobodies for the design of glioblastoma targeting therapy]
    2018 ►
  28. Smrdel Uroš; Skoblar Vidmar Marija; Smrdel Aleš
    Glioblastoma in patients over 70 years of age
    2018 ►
  29. Vidak Marko; Jovchevska Ivana; Šamec Neja; Zottel Alja; Liović Mirjana; Rozman Damjana; Džeroski Sašo; Juvan Peter; Komel Radovan
    Meta-analysis and experimental validation identified FREM2 and SPRY1 as new glioblastoma marker candidates
    2018 ►
  30. Jovchevska Ivana
    Sequencing the next generation of glioblastomas
    2018 ►
  31. Zupanec Neja; Jovchevska Ivana; Stojan Jure; Zottel Alja; Liović Mirjana; Myers Michael P.; Muyldermans Serge; Šribar Jernej; Križaj Igor; Komel Radovan
    Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting
    2018 ►
  32. Georgakis Marios K.; Papathoma Paraskevi; Ryzhov Anton; Eser Sultan; Taraszkiewicz Łukasz; Sekerija Mario; Žagar Tina; Antunes Luis; Zborovskaya Anna A.; Bastos Joana
    Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program
    2017 ►
  33. Komel Radovan
    Novel approaches in looking for glioblastoma - specific protein markers, and targeting
    2017 ►
  34. Vidak Marko; Liović Mirjana; Jovchevska Ivana; Rozman Damjana; Džeroski Sašo; Komel Radovan
    Bioinformatic identification and experimental validation of new glioblastoma stem cell marker candidates
    2017 ►
  35. Zottel Alja; Zupanec Neja; Jovchevska Ivana; Šribar Jernej; Križaj Igor; Zadravec-Zaletel Lorna; Komel Radovan
    Evaluation of nanobodies against potential glioblastoma biomarkers
    2017 ►
  36. Breznik Barbara
    Niše tumorskih matičnih celic kot obetavne terapevtske tarče
    2017 ►
  37. Jovchevska Ivana; Zupanec Neja; Urlep Žiga; Vranič Andrej; Matos Boštjan; Limbäck-Stokin Clara; Muyldermans Serge; Myers Michael P.; Buzdin Anton A.; Petrov Ivan; Komel Radovan
    Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
    2017 ►
  38. Vidak Marko; Liović Mirjana; Džeroski Sašo; Rozman Damjana; Komel Radovan
    Discovery of new glioblastoma stem cell marker candidates by analyzing mRNA microarray data from NCBI GEO database
    2017 ►
  39. Zupanec Neja; Jovchevska Ivana; Zottel Alja; Liović Mirjana; Myers Michael P.; Podergajs Neža; Muyldermans Serge; Komel Radovan
    Identification of an anti-T nanobody in VHH library and its cytotoxic effect on glioblastoma cells
    2017 ►
  40. Smrdel Uroš; Popović Mara; Zwitter Matjaž; Boštjančič Emanuela; Zupan Andrej; Kovač Viljem; Glavač Damjan; Bokal Drago; Jerebic Janja
    Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
    2016 ►
  41. Vidak Marko; Rozman Damjana; Liović Mirjana; Komel Radovan
    Search of new glioblastoma stem cell markers by comparing microarrays data from the NCBI geo database, and experimental validation of those markers in glioma cell lines
    2016 ►
  42. Zottel Alja; Jovchevska Ivana; Zupanec Neja; Komel Radovan
    Glioblastoma multiforme and nanobodies
    2016 ►
  43. Komel Radovan
    Functional analysis of proteomic biomarkers and targeting glioblastoma stem cells
    2016 ►
  44. Jovchevska Ivana; Zupanec Neja; Urlep Žiga; Vranič Andrej; Matos Boštjan; Limbäck-Stokin Clara; Muyldermans Serge; Myres Michael P.; Buzdin Anton A.; Petrov Ivan; Komel Radovan
    Nanobody-based approach for the selection of novel differentially expressed proteins in glioblastoma multiforme and their potential use as biomarkers for class prediction
    2016 ►
  45. Verbovšek Urška; Lah Turnšek Tamara; Noorden Cornelis J. F. van
    Cathepsin K as a potential tumor marker in glioblastoma multiforme
    2016 ►
  46. Vidak Marko; Rozman Damjana; Liović Mirjana; Komel Radovan
    Search of new glioblastoma stem cell markers by analysis of NCBI GEO datasets, and experimental validation of those markers in glioma cell lines
    2016 ►
  47. Komel Radovan
    Potential human glioblastoma cancer markers identified with nanobody-based reverse proteomic approach
    2016 ►
  48. Jovchevska Ivana
    Exploiting nanobodies in the search for protein markers of glioblastoma multiforms
    2015 ►
  49. Vittori Miloš; Breznik Barbara; Gredar Tajda; Hrovat Katja; Bizjak-Mali Lilijana; Lah Turnšek Tamara
    Imaging of human glioblastoma cells and their interactions with mesenchymal stem cells in the zebrafish (Danio rerio) embryonic brain
    2016 ►
  50. Bisdas Sotirios; Smrdel Uroš; Bajrović Fajko; Šurlan Popović Katarina
    Assessment of progression-free-survival in glioblastomas by intratreatment dynamic contrast-enhanced MRI
    2016 ►
  51. Motaln Helena; Schuchhardt Johannes; Stec Karol; Breznik Barbara; Ulrich Henning; Lah Turnšek Tamara
    Paradoxical role of mesenchymal stem cells in the glioblastoma microenvironment
    2014 ►
  52. Mesti Tanja; Ocvirk Janja
    Evaluation of the glioblastoma cell lines response to arsenic trioxide (As [sub] 2O [sub] 3) and bevacizumab according to the IDH1 mutation status
    [Odgovor glioblastomskih celičnih linij na arzenov trioksid (As [spodaj] 2O [spodaj] 3) in bevacizumab glede na prisotnost IDH1 mutacije]
    2015 ►
  53. Panjan Peter; Štrukelj Borut
    Razvoj genskega zdravljenja pri glioblastomu
    [Development of gene therapy for glioblastoma]
    2014 ►
  54. Matos Boštjan; Boštjančič Emanuela; Popović Mara; Glavač Damjan
    Dynamic of expression of eleven micrornas in recurrent glioblastoma before and after treatment with radiotherapy and chemotherapy
    2015 ►
  55. Vidak Marko; Rozman Damjana; Komel Radovan
    Effects of flavonoids from food and dietary supplements on glial and glioblastoma multiforme cells
    2015 ►
  56. Glavač Damjan
    The predictive value of MGMT promotor methylation in glioblastoma patients
    2015 ►
  57. Boštjančič Emanuela; Matos Boštjan; Popović Mara
    microRNA signatures in operable recurrent glioblastoma before and after treatment
    2015 ►
  58. Smrdel Uroš; Popović Mara; Zwitter Matjaž; Boštjančič Emanuela; Zupan Andrej; Kovač Viljem; Glavač Damjan; Bokal Drago; Jerebic Janja
    Long-term survival in glioblastoma
    2015 ►
  59. Vidak Marko; Jovčevska Ivana; Zupanec Neja; Komel Radovan
    Analysis of communication networks of glioblastoma stem cell markers
    2015 ►
  60. Zupanec Neja; Jovčevska Ivana; Liović Mirjana; Komel Radovan
    Localization and cytotoxicity of nanobodies directed against glioblastoma multiforme biomarkers
    2015 ►
  61. Mihalic Filip; Zupanec Neja; Jovčevska Ivana; Komel Radovan; Liović Mirjana
    Glioblastoma specific nanobodies
    2015 ►
  62. Komel Radovan
    TRIM28 and beta-actin as potential biomarkers for glioblastoma targeting
    2015 ►
  63. Vidak Marko; Jovčevska Ivana; Zupanec Neja; Komel Radovan
    Cell communication network analysis of glioblastoma stem cell marker candidates [beta]-actin, CD9, FTL, S100A9 and TRIM28
    2015 ►
  64. Verbovšek Urška; Motaln Helena; Rotter Ana; Atai Nadia A.; Gruden Kristina; Noorden Cornelis J. F. van; Lah Turnšek Tamara
    Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma
    2014 ►
  65. Verbovšek Urška; Motaln Helena; Levičar Nataša; Rotter Ana; Lah Turnšek Tamara
    The duality of stem cells
    2013 ►
  66. Komel Radovan
    Looking for proteomic biomarkers at glioblastoma multiforme
    2015 ►
  67. Strojnik Tadej; Kavalar Rajko
    Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in a chick embryo model
    2009 ►
  68. Mesti Tanja; Ebert Moltara Maja; Boc Marko; Reberšek Martina; Ocvirk Janja
    Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
    2015 ►
  69. Smrdel Uroš; Šečerov Ermenc Ajra
    Treatment and survival of glioblastoma patients in Slovenia, 1997-2006
    2008 ►
  70. Komel Radovan; Jovčevska Ivana; Zupanec Neja; Kočevar Nina; Muyldermans Serge
    Can we find specific glioblastoma stem cell markers with a proteomic approach?
    2014 ►
  71. Popović Mara
    Glioblastoma
    [(Glioblastoma)]
    2013 ►
  72. Jovčevska Ivana; Zupanec Neja; Kočevar Nina; Cesselli Daniela; Podergajs Neža; Limbäck-Stokin Clara; Myers Michael P.; Muyldermans Serge; Hassanzadeh Ghassabeh Gholamreza; Motaln Helena; Ruaro Maria Elisabetta; Bourkoula Evgenia; Lah Turnšek Tamara; Komel Radovan
    TRIM28 and [beta]-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers
    2014 ►
  73. Vittori Miloš; Podergajs Neža; Motaln Helena; Lah Turnšek Tamara
    Orthotopic xenotransplantation of human cancer cells into zebrafish embryos for the in vivo study of glioblastoma
    2014 ►
  74. Breznik Barbara; Motaln Helena; Golob Monika; Lah Turnšek Tamara
    Proteolytic cascades in glioblastoma and mesenhymal stem cells direct cross-talk
    2014 ►
  75. Zupančič Klemen; Blejec Andrej; Herman Ana; Veber Matija; Verbovšek Urška; Koršič Marjan; Knežević Miomir; Rožman Primož; Lah Turnšek Tamara; Gruden Kristina; Motaln Helena
    Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach
    [[Ugotavljanje možnih plazemskih bioloških označevalcev pri glioblastomu z uporabo proteomske tehnike mikromrež s protitelesi]]
    2014 ►
  76. Vittori Miloš; Podergajs Neža; Motaln Helena; Breznik Barbara; Lah Turnšek Tamara
    The zebrafish embryonic brain as the area of tumour cell xenotransplantation for glioblastoma progression studies
    2014 ►
  77. Mesti Tanja; Savarin Philippe; Triba Mohamed N.; Le Moyec Laurence; Ocvirk Tanja; Banissi Claire; Carpentier Antoine F.
    Metabolic impact of anti-angiogenic agents on U87 glioma cells
    2014 ►
  78. Primon Monika; Lah Turnšek Tamara
    Učinek arzenovega trioksida in utišanja katepsina L ter vpliv mezenhimskih matičnih celic na celice glioblastoma
    2014 ►
  79. Smrdel Uroš; Kovač Viljem; Popović Mara; Zwitter Matjaž
    Glioblastoma patients in Slovenia from 1997 to 2008
    2014 ►
  80. Podergajs Neža; Lah Turnšek Tamara
    Vloga signalnih poti EGFR in FGFR ter novih označevalcev pri glioblastomskih matičnih celicah
    2013 ►
  81. Strojnik Tadej; Šmigoc Tomaž; Lah Turnšek Tamara
    Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma
    2014 ►
  82. Podergajs Neža; Brekka Narve; Radlwimmer Bernhard; Herold-Mende Christel; Talasila Krishna M.; Tiemann Katja; Rajčević Uroš; Lah Turnšek Tamara; Bjerkvig Rolf; Miletic Hrvoje
    Expansive growth of two glioblastoma stem-like cell lines is mediated by bFGF and not by EGF
    2013 ►
  83. Podergajs Neža; Rajčević Uroš; Verbovšek Urška; Motaln Helena; Niclou Simone P.; Jimenez Connie R.; Herold-Mende Christel; Lah Turnšek Tamara
    CD9 is a potential stem cell marker of glioblastoma stem-like cells
    2013 ►
  84. Kočevar Nina; Jovčevska Ivana; Cesselli Daniela; Kastelic Damjana; Muyldermans Serge; Komel Radovan
    Llama heavy chain antibodies as means to identify glioblastoma biomarkers
    2013 ►
  85. Verbovšek Urška; Motaln Helena; Rotter Ana; Gruden Kristina; Noorden Cornelis J. F. van; Lah Turnšek Tamara
    Cathespin K is upregulated in the brain tumour glioblastoma multiforme
    2013 ►
  86. Jovčevska Ivana; Kočevar Nina; Komel Radovan
    Glioma and glioblastoma how much do we (not) know? (Review)
    2013 ►
  87. Verbovšek Urška; Motaln Helena; Rotter Ana; Gruden Kristina; Noorden Cornelis J. F. van
    Cathepsin K is upregulated in the brain tumour glioblastoma multiforme
    2013 ►
  88. Petersen Kjell; Rajčević Uroš; Rahim Siti Aminah Abdul; Jonassen Inge; Kalland Karl-Henning; Jimenez Connie R.; Bjerkvig Rolf; Niclou Simone P.
    Gene set based integrated data analysis reveals phenotypic differences in a brain cancer model
    2013 ►
  89. Komel Radovan; Jovchevska Ivana; Kočevar Nina; Muyldermans Serge; Kastelic Damjana; Cesselli Daniela
    Llama heavy-chain antibodies in search for glioblastoma stem cell biomarkers with diagnostic/prognostic and therapeutic values
    2013 ►
  90. Obrez Mateja; Motaln Helena; Tajnšek Urška; Lah Turnšek Tamara
    Vloga matičnih celic pri napredovanju in zdravljenju glioma
    [#The #role of stem cells in glioma progression and therapy]
    2013 ►
  91. Tajnšek Urška; Motaln Helena; Rotter Ana; Gruden Kristina; Van Noorden Cornelis JF; Lah Turnšek Tamara
    Glioblastoma transcriptomics
    2013 ►
  92. Primon Monika; Huszthy Peter C.; Motaln Helena; Talasila Krishna M.; Bjerkvig Rolf; Lah Turnšek Tamara
    Cathepsin L silencing affects arsenic trioxide - mediated cytotoxicity and apoptosis in U87MG spheroids
    2013 ►
  93. Podergajs Neža; Rajčević Uroš; Tajnšek Urška; Motaln Helena; Niclou Simone P.; Jimenez Connie R.; Herold Mende Christel; Miletic Hrvoje; Bjerkvig Rolf; Lah Turnšek Tamara
    Transmembrane protein CD9 is a potential selective stem cell marker of glioblastoma stem-like cells
    2013 ►
  94. Obrez Mateja; Motaln Helena; Gruden Kristina; Jürchott Kathrin; Lah Turnšek Tamara
    BDKRB1 expression differentially changes in GBM and MSC(in) direct co-cultures
    2013 ►
  95. Kološa Katja; Motaln Helena; Lah Turnšek Tamara
    Mesenchymal stem cells reduce the stemness of glioblastoma stem cells
    2013 ►
  96. Popović Mara
    Glioblastom
    [(Glioblastoma)]
    2012 ►
  97. Lah-Turnšek Tamara; Motaln Helena; Gruden Kristina; Hren Matjaž; Rotter Ana; Schichor Christian
    Cancer associated stem cells in glioblastoma and their clinical relevance
    2012 ►
  98. Šimenc Janez; Lipnik-Štangelj Metoda
    Staurosporine induces different cell death forms in cultured rat astrocytes
    2012 ►
  99. Vrabec Matej; Van Cauter Sofie; Himmelreich Uwe; Van Gool Stefaan W; Sunaert Stefan; De Vleeschouwer Steven; Šuput Dušan; Demaerel Philippe
    MR perfusion and diffusion imaging in the follow-up of recurrent glioblastoma treated with dendritic cell immunotherapy: a pilot study
    2011 ►
  100. Strojnik Tadej
    Prognostic significance of immunohistochemical markers in glioma patients
    2011 ►

   1 38 138  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics